| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 11.60 | 0.07 (+0.65%) | 9.66 - 12.06 | -- |
Market data as of 12:00AM 06/18/13. Quotes are delayed by at least 15 min.
The fundamental investment objective of the Fund is to seek to provide long-term capital appreciation by investing primarily in equity securities of companies located outside of Canada and the United States.
| Total Return | 11.86% |
|---|---|
| Yield (Trailing 12 Mo.) | -- |
| Expense Ratio | -- |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $500.00 |
| Management Tenure | 2 Years |
| Fund Inception | 08/24/2011 |
| Timeframe | MUTUAL:MMF9520 | S&P 500 | International Equity |
|---|---|---|---|
| 1 Month | -1.05% | 2.34% | 1.18% |
| 3 Month | 0.32% | 8.22% | 3.51% |
| Year-to-Date | 5.33% | 15.37% | 9.79% |
| 1 Year | -- | 27.28% | 27.86% |
| 3 Year | -- | 16.87% | 8.48% |
| 5 Year | -- | 5.43% | -1.83% |
| 10 Year | -- | 7.58% | 4.35% |
| Since Inception | 11.86% | 10.42% | -- |
| Basic Materials | 8.29% | |
|---|---|---|
| Consumer Cyclical | 8.73% | |
| Financial Services | 22.34% | |
| Real Estate | 2.50% | |
| Consumer Defensive | 11.29% | |
| Healthcare | 10.38% | |
| Utilities | 4.16% | |
| Communication Services | 6.62% | |
| Energy | 9.47% | |
| Industrials | 12.99% | |
| Technology | 3.23% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | 0.00 | 0.00 | 0.00 | ||
| Bond | 0.00 | 0.00 | 0.00 | ||
| Other | 0.00 | 0.00 | 0.00 | ||
| Foreign Stock | 0.00 | 96.36 | 96.36 | ||
| Foreign Bond | 0.00 | 0.00 | 0.00 | ||
| Total | 0.00 | 96.36 | 96.36 | ||
| Cash | 0.49 | 4.13 | 3.64 | ||
| Total Net Assets | $224.81M |
|---|---|
| Total Stock Holdings | 119 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Nestle SA | 0.68% | 1.39% |
| HSBC Holdings PLC | 7.93% | 1.25% |
| Novartis AG | 14.18% | 1.23% |
| Allianz SE | 14.93% | 1.22% |
| Barclays PLC | 14.74% | 1.19% |
| Credit Suisse Group | -- | 1.15% |
| Heineken Holding NV | -- | 1.14% |
| GlaxoSmithKline PLC | 24.67% | 1.13% |
| Kingfisher PLC | 12.26% | 1.10% |
| DNB ASA. | -- | 1.09% |
| Valuation | MUTUAL:MMF9520 | Category Range |
|---|---|---|
| Price/Earnings | 13.60 | |
| Price/Book | 1.25 | |
| Price/Sales | 0.77 | |
| Price/Cash Flow | 6.94 | |
| Dividend Yield | 3.07 | |
| LT Earnings | 9.16 | |
| Historical Earnings | 9.19 | |
| Sales Growth | 4.3 | |
| Cash-Flow Growth | -2.86 | |
| Book-Value Growth | 4.46 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall | ||
| Risk | ||
| Return |
| Pretax Return | -- |
|---|---|
| Tax-adjusted Return | -- |
| Tax Cost Ratio | -- |
| Potential Cap Gains | -- |
